|
B3GALNT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.44089209850063E-16 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
6.52811138479592E-14 |
| Normal-vs-Stage3 |
1.62503344114384E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
4.982800E-01 |
| Stage1-vs-Stage3 |
3.995200E-01 |
| Stage1-vs-Stage4 |
3.8826999999575E-06 |
| Stage2-vs-Stage3 |
9.507600E-01 |
| Stage2-vs-Stage4 |
1.257900E-02 |
| Stage3-vs-Stage4 |
1.341190E-03 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.44089209850063E-16 |
| Normal-vs-AfricanAmerican |
2.31779999970705E-07 |
| Normal-vs-Asian |
1.69875224997895E-12 |
| Caucasian-vs-AfricanAmerican |
2.033400E-01 |
| Caucasian-vs-Asian |
8.271600E-01 |
| AfricanAmerican-vs-Asian |
2.270600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62458935193399E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
3.479600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
3.33066907387547E-16 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.64532999999967E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.816600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.232200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.377800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.727800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.390400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.003200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.054400E-01 |
| Classical-VS-Follicular |
4.628000E-01 |
| Classical-VS-Other |
3.650600E-01 |
| Classical-VS-Normal |
2.05391259555654E-14 |
| Tall-VS-Follicular |
6.210800E-01 |
| Tall-VS-Other |
5.826000E-01 |
| Tall-VS-Normal |
1.80966353013901E-14 |
| Follicular-VS-Other |
5.468000E-01 |
| Follicular-VS-Normal |
1.62458935193399E-12 |
| Other-VS-Normal |
3.60780000000505E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
7.504300E-02 |
|
|
